Although the underlying pathological mechanisms of these associations are not well-established, an accumulating body of research supports the potential for a causal role for reduced insulin sensitivity in increasing the risk of morbidity related to atherosclerosis, particularly for CAD and ischemic stroke (12–19). This evidence concerns the gene INS and coronary artery disorder.